On demand

Cooley Rx Series

Life Sciences Litigation: Considerations for the US Inflation Reduction Act and Expanded March-In Rights

March 20, 2024
Event details
March 20, 2024
12:00 – 1:00 pm Pacific Standard Time

Event summary

Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. Join us as we discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.

Life Sciences Litigation: Considerations for the US Inflation Reduction Act and Expanded March-In Rights

In 2024, the US Centers for Medicare & Medicaid Services will release the maximum fair price for the first 10 drugs selected for the Medicare Drug Price Negotiation Program created under the Inflation Reduction Act (IRA). In addition, the National Institute of Standards and Technology will release guidance – including the use of price – for exercising march-in rights under the Bayh-Dole Act. In this webinar, Chad Shear, experienced Cooley life sciences patent trial lawyer, and Vince Sampson, who leads the firm’s public policy practice, discussed the process and impacts of the IRA’s drug pricing program – and what expanded march-in rights could mean for federally funded life science research.

View on demand

For more information, please email Megan Senerchia.

Cooley Rx programming

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.